Type 1 diabetes

Ambulance clinician use of capillary blood ketone meters to improve emergency hyperglycaemia care: A stepped‐wedged controlled, mixed‐methods feasibility study

Diabet MedPublished Mixed-methods feasibility study

Authors' conclusion

Ambulance capillary blood ketone meter use was deemed feasible, safe and acceptable. Opportunities for improved clinical decision making, support and safety-netting, as well as in-hospital DKA care, were recognised. As participant recruitment was below progression threshold, it is recommended that future-related research considers alternative trial designs.

Study context

Population
Ambulance patients with hyperglycaemia (capillary blood glucose >11.0 mmol/L) or diabetes and unwell; plus 20 ambulance and ED clinicians interviewed20 clinicians interviewed
Participants
388 patients
Comparison
Ambulance capillary blood ketone meter use with paramedic-led fluid therapy for 'high-risk' diabetic ketoacidosis (DKA) vs control
  • Interventionn = 185
  • Controln = 203reference
Outcome
Feasibility, safety and acceptability of ambulance clinician use of capillary blood ketone meters for 'high-risk' DKA recognition and fluid initiation
Methodological detailsstepped-wedge controlled
  • Stepped-wedge controlled

Main finding

As reported in the abstract

'High-risk' DKA identification

Further findings

Pre-hospital fluid therapy in hospital-diagnosed DKA participants

Diabetes type among participants

T1D
18.5%
T2D
74.3%

Clinician interviews

Key themes: clinical assessment, ambulance DKA fluid therapy, clinical handovers; decision support tool; hospital DKA management; barriers to hospital DKA care

Original publication

Ambulance clinician use of capillary blood ketone meters to improve emergency hyperglycaemia care: A stepped‐wedged controlled, mixed‐methods feasibility study. Diabet Med. Published 9 June 2024. doi:10.1111/dme.15372

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.